Pituitary Tumor Syndromes

The pituitary gland, often called the body’s “master gland,” sits at the base of the brain and orchestrates critical hormonal functions. When a tumor, almost always a benign pituitary adenoma, develops here, it can disrupt this delicate control system in one of two primary ways: by secreting excess hormones or by pressing on nearby neural and vascular structures. Understanding these syndromes is essential because their presentations are often subtle and mistaken for other conditions, but accurate diagnosis leads to highly effective, often life-changing, treatments.

Mechanisms of Disease: Excess Hormones vs. Mass Effect

Pituitary adenomas are categorized by their function and size. Their clinical impact stems from two distinct, and sometimes overlapping, mechanisms. First, hormone excess occurs when the tumor cells autonomously produce one or more pituitary hormones, leading to specific endocrine syndromes like acromegaly or Cushing disease. The type of hormone overproduced defines the tumor: prolactinoma, somatotroph (growth hormone), corticotroph (ACTH), and others.

Second, the mass effect refers to the physical compression of structures surrounding the pituitary gland. This is most common with non-functioning adenomas, which do not secrete excess hormones, and with larger tumors termed macroadenomas (greater than 10 mm in diameter). The optic chiasm, located directly above the pituitary, is particularly vulnerable; compression here leads to classic visual field defects. Larger masses can also compress the normal pituitary tissue itself, causing hormone deficiencies (hypopituitarism), or impinge on cranial nerves or the cavernous sinuses.

Prolactinoma: The Medical Management Success Story

Prolactinomas are the most common functional pituitary adenomas. They secrete excess prolactin, the hormone that stimulates milk production. In premenopausal women, this typically presents with galactorrhea (inappropriate milk production) and amenorrhea (loss of menstrual periods) due to suppression of gonadotropin-releasing hormone. In men, symptoms are often subtler, including decreased libido, erectile dysfunction, or infertility, and may be overlooked until a mass effect causes headaches or vision problems.

Diagnosis involves confirming elevated serum prolactin levels, with levels often correlating with tumor size. The cornerstone of treatment is medical, not surgical. Dopamine agonists like cabergoline or bromocriptine are first-line. These medications mimic dopamine, the natural inhibitor of prolactin secretion, causing the tumor to shrink and prolactin levels to normalize in most patients. Surgery is reserved for patients who are intolerant or resistant to these medications.

Acromegaly: Growth Hormone Excess and Its Systemic Toll

Acromegaly results from a somatotroph adenoma secreting excess growth hormone (GH). In adults, this leads to the characteristic disfiguring and systemic effects: coarse facial features, enlarged hands and feet (increased ring or shoe size), jaw protrusion (prognathism), and thickened skin. More critically, it causes severe health complications including cardiomyopathy, hypertension, diabetes mellitus, sleep apnea, and an increased risk of colon polyps.

Diagnosis is a two-step process. First, an elevated IGF-1 level (a liver-produced hormone stimulated by GH) is used for screening because it is more stable than pulsatile GH. The confirmatory test is the oral glucose tolerance test; failure to suppress GH levels confirms the diagnosis. The primary and preferred treatment for most patients is surgical resection, typically via a transsphenoidal approach, to remove the tumor and achieve biochemical cure. For residual disease, medical therapies (somatostatin analogs, GH receptor antagonists) or radiation may be used.

Cushing Disease: When the Pituitary Drives Excess Cortisol

Cushing disease is specifically caused by a pituitary corticotroph adenoma secreting excess adrenocorticotropic hormone (ACTH). This ACTH overstimulates the adrenal glands, leading to chronic excess cortisol production. The resulting Cushing syndrome manifests with central obesity, moon face, purple striae, proximal muscle weakness, hypertension, glucose intolerance, and psychological changes. It is a severe condition with high morbidity and mortality if untreated.

Differentiating Cushing disease (pituitary source) from other causes of Cushing syndrome (e.g., adrenal tumor, ectopic ACTH) is a diagnostic challenge. Tests include late-night salivary cortisol, low-dose dexamethasone suppression tests, and measurement of ACTH. Once a pituitary source is confirmed, the treatment of choice is selective transsphenoidal surgery to remove the adenoma. This offers the chance of immediate cure. If surgery fails or is not possible, options include medication, bilateral adrenalectomy, or radiation therapy.

Non-functioning Pituitary Adenomas: The Silent Mass

Non-functioning adenomas (NFAs) do not secrete biologically active hormones in excess. They are often clinically silent until they grow large enough to cause a mass effect. The most common and telling presentation is bitemporal hemianopsia, a visual field defect where the outer halves of both visual fields are lost due to compression of the optic chiasm. Patients may also present with headaches, hypopituitarism from crushed normal gland tissue, or, rarely, pituitary apoplexy (sudden bleeding into the tumor).

Management is driven by the presence of symptoms or threat from mass effect. Asymptomatic small microadenomas can often be monitored with regular MRI and visual field testing. However, symptomatic macroadenomas, especially those causing visual defects, typically require surgical decompression via transsphenoidal surgery to relieve pressure on the optic apparatus. Unlike functioning tumors, there is no medical therapy to shrink most NFAs, so surgery is the primary definitive intervention.

Common Pitfalls

1. Misattributing Prolactin Elevation: A moderately elevated prolactin level can be caused by a large non-functioning adenoma compressing the pituitary stalk (disrupting dopamine flow), not by a prolactinoma. This "stalk effect" rarely raises prolactin above 150 ng/mL. Mistaking this for a prolactinoma could lead to inappropriate dopamine agonist therapy instead of necessary surgery for the mass.
2. Delaying Diagnosis of Acromegaly: The physical changes of acromegaly are insidious, occurring over years. Patients and providers may attribute them to normal aging. Always compare current photographs to those from 5-10 years prior when suspicion arises. Delayed diagnosis allows irreversible cardiac and metabolic complications to develop.
3. Overlooking Subtle Visual Field Defects: Patients with slowly progressive bitemporal hemianopsia may not report vision loss because central acuity is preserved until late. They may instead complain of bumping into doorways or spilling drinks. Formal visual field testing (perimetry) is mandatory for any pituitary macroadenoma, even if the patient denies vision problems.
4. Incomplete Workup for Cushing Syndrome: Jumping to treatment without precise localization of the ACTH source is a critical error. An ectopic ACTH-secreting tumor (e.g., from the lung) requires a completely different treatment approach than a pituitary adenoma. Always complete the full differential diagnostic protocol, which may include inferior petrosal sinus sampling (IPSS).

Summary

• Pituitary adenomas cause disease through hormone excess (prolactin, GH, ACTH) or mass effect on surrounding structures like the optic chiasm.
• Prolactinomas are first-line treated with dopamine agonists (e.g., cabergoline), which effectively lower prolactin levels and shrink tumors.
• Acromegaly, from GH excess, is diagnosed with IGF-1 and a glucose suppression test, and surgical resection is the primary curative treatment.
• Cushing disease, caused by a pituitary ACTH-secreting tumor, leads to hypercortisolism and is best treated with selective transsphenoidal surgery.
• Non-functioning macroadenomas often present with visual field defects (bitemporal hemianopsia) due to optic chiasm compression and typically require surgical decompression.